Professional Supplier High Purity Ara290 Peptide CAS 1208243-50-8 Top-Grade Lyophilized Powder

• Customization: Available
• CAS No.: 1208243-50-8
• Formula: N/a
• Model NO.: 1208243-50-8
• EINECS: N/a
• Type: for Research Use Only
• Appearance: Powder
• Quality: Refined
• Colour: White
• Content: Standard
• Usage: Laboratory Reagents
• Source: Dry Powder
• Habit Appellation: Fine Chemicals
• Application: Scientific Research
• Property: Protein and Peptide
• Specific Usage: Research Use Only
• Note: No Tfa Salt
• From: Authoried Regluar Workshop
• Raw Powder: 1g/Bottle
• Vials: 2mg 5mg 10mg
• Attention: Research Use Only
• Transport Package: Customized
• Specification: 1G/Bottle 50mg 100mg per vial
• Trademark: Hoconbio
• Origin: China
• Production Capacity: 50000kits Per Month

Product Description

Product Name	ARA-290
Other	Cibinetide
CAS NO.	1208243-50-8
Appearance	White freeze-dried powder
Purity	98% HPLC
Application	Research peptides
Shelf Life	24 Months
Storage	Store at a temperature of 2-8 degrees, protected from light.

ARA-290 is a peptide that is derived from e rythropoietin (EPO). EPO has been utilized for decades because of its ability to stimulate red blood cell production within bone marrow. It can also alter a patient's blood pressure, promote cell survival, and create a neuroprotective effect.
While ARA-290 does not stimulate red blood cell production, it does offer pain-relieving and neuroprotective effects.
It also has the potential to stimulate wound repair in patients with chronic diabetes, but this property is still being researched. 
ARA-290 is being studied as a potential treatment for systemic lupus erythematosus, as well.


Application & Function
The full scope of ARA-290s benefits is still being researched. However, it has the potential to decrease the user's inflammatory pathways through a process known as paracrine signaling. It has also been linked to reduced HbA1c and improved cholesterol numbers. Studies that have produced these results are still in the trial stages.
Perhaps the most appealing possibility for ARA-290 is that it may have the ability to reduce neuropathic symptoms and stimulate natural wound repair processes. 
This peptide serves as an exciting treatment option for patients that are dealing with chronic neuropathic pain and diabetes-related ailments.